Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
The Journal of Invasive Cardiology|April 4, 2015
Comparison of fluoro and cine coronary angiography: balancing acceptable outcomes with a reduction in radiation doseAyhan Olcay, Ekrem Guler, Ibrahim Oguz Karaca, et al.
Kardiologia Polska|August 3, 2013
Adding lipoprotein(a) levels to the GRACE score to predict prognosis in patients with non-ST elevation acute coronary syndromeEkrem Guler, Cetin Gecmen, Gamze Babur Guler, et al.
Minerva Cardiology and Angiology|April 25, 2020
Outcomes of the novolimus-eluting bioresorbable vascular scaffold in real world clinical practiceBeytullah Cakal, Sinem Cakal, Oguz Karaca, et al.
Postepy W Kardiologii Interwencyjnej = Advances in Interventional Cardiology|February 18, 2021
Long-term comparison of everolimus- vs. novolimus-eluting bioresorbable vascular scaffolds in real world patientsBeytullah Cakal, Sinem Cakal, Oguz Karaca, et al.
Journal of Cardiac Failure|April 9, 2016
Native Electrocardiographic QRS Duration after Cardiac Resynchronization Therapy: The Impact on Clinical Outcomes and PrognosisOguz Karaca, Beytullah Cakal, Mehmet Onur Omaygenc, et al.
The International Journal of Cardiovascular Imaging|February 2, 2018
Effect of cardiac resynchronization therapy on mitral valve geometry: a novel aspect as "reversed mitral remodeling"Oguz Karaca, Beytullah Cakal, Mehmet Onur Omaygenc, et al.
Journal of Clinical Medicine|July 2, 2021
Switching Ticagrelor to 600 mg or 300 mg Clopidogrel Loading Bridge in Patients with Unstable AnginaSinem Cakal, Beytullah Cakal, Zafer Güven, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|January 29, 2016
Adjusting the QRS Duration by Body Mass Index for Prediction of Response to Cardiac Resynchronization Therapy: Does One QRS Size Fit All?Oguz Karaca, Mehmet O Omaygenc, Beytullah Cakal, et al.
Congestive Heart Failure (Greenwich, Conn.)|May 17, 2012
Serum carbohydrate antigen 125 levels in nonischemic dilated cardiomyopathy: a useful biomarker for prognosis and functional mitral regurgitationOguz Karaca, Gamze B Guler, Ekrem Guler, et al.
Pageof 4